Discovery of novel small-molecule binders targeting IL-6 receptor conformational ensembles to regulate IL-6 signaling.
INTRODUCTION Interleukin-6 (IL-6) signaling via its receptor (IL-6R) is a central driver of inflammation and immune-related diseases. Although monoclonal antibodies targeting this pathway are clinically effective, their limitations, including high costs and parenteral administration, create an urgent need for orally av...